Artificial intelligence in prostate cancer: Definitions, current research, and future directions.
Artificial intelligence
Computational pathology
Machine learning
Prostate cancer
Urologic oncology
Journal
Urologic oncology
ISSN: 1873-2496
Titre abrégé: Urol Oncol
Pays: United States
ID NLM: 9805460
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
received:
05
12
2021
revised:
19
01
2022
accepted:
10
03
2022
pubmed:
18
4
2022
medline:
18
5
2022
entrez:
17
4
2022
Statut:
ppublish
Résumé
Multiple novel modalities tasking artificial intelligence based computational pathology applications and integrating other variables, such as risk factors, tumor microenvironment, genomic testing data, laboratory findings, clinical history, and radiology findings, will improve diagnostic consistency and generate a synergistic diagnostic workflow. In this article, we present the concise and contemporary review on the utilization of artificial intelligence in prostate cancer and identify areas for possible future applications.
Identifiants
pubmed: 35430139
pii: S1078-1439(22)00077-1
doi: 10.1016/j.urolonc.2022.03.003
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
262-270Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.